Related Experiment Video
Updated: May 24, 2025
05:09
Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
Published on: April 28, 2023
867
Drug-coated balloon dilation for female urethral stricture
Hannah S Thomas1, Noah Stern2, Sarah Neu1,2
1Division of Urology, University of Toronto, Toronto, ON, Canada.
Urology Case Reports
|March 4, 2025
Summary
Drug-coated balloon dilation (DCB) shows promise for treating female urethral stricture disease (USD). This case report details a successful six-month outcome, advocating for further research into DCB for this condition.
Area of Science:
- Urology
- Medical Devices
- Regenerative Medicine
Background:
- Urethral stricture disease (USD) affects both males and females, though treatment options for female USD are limited.
- Drug-coated balloon (DCB) dilation has proven effective for male USD, but its application in females is largely unexplored.
Observation:
- This report documents the second known case of DCB utilization for female USD.
- The study details the perioperative experience and provides six-month follow-up outcomes.
Findings:
- The case demonstrates a positive six-month outcome following DCB treatment for female USD.
- The procedure was successfully performed, indicating feasibility.
Implications:
- This case suggests DCB may be a viable treatment option for female USD.
- Further multi-center studies are crucial to validate these findings and establish DCB's role in managing female USD.
Related Concept Videos
01:21Drugs for Treatment of Constipation-Predominant IBS
125
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
125
01:23Antihypertensive Drugs: Vasodilators
455
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
455
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
142
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
142